Exactech Announces First Implantation of New Alteon™ Tapered Wedge Femoral Stem
August 13 2014 - 8:17AM
Business Wire
New Hip Replacement Design Targets Improvements
for Hip Patients
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, is proud to announce the first implantation of
the Alteon™ Tapered Wedge Femoral Stem. The surgery took place at
Franciscan St. Francis Health in Carmel, Ind., and was performed by
orthopaedic surgeon Jeffery Pierson, MD, a member of the design
team for this new hip replacement implant.
“It has been an incredibly gratifying experience to be directly
involved in the design and development of a device that performed
as well in surgery as I anticipated it would,“ said Pierson.
“Clinically relevant improvements to devices, such as the ones we
made with the new Tapered Wedge Stem, allow us to continue to
provide the best standard of care to our patients.”
Over the past two years, Dr. Pierson and Michael Kang, MD, from
the Insall-Scott-Kelly Institute in New York, N.Y., consulted with
Exactech to bring to market a newly designed stem that addresses
several clinical challenges that many surgeons face with current
product design philosophies.
The Tapered Wedge Stem, which is currently in the pilot launch
phase of release, incorporates specific features designed to
achieve axial and rotational mechanical stability between the
lateral and medial cortices of the femoral canal. This product will
be expanding to a limited number of additional sites within the
coming months, and company officials report a full launch within
the U.S. is expected to take place in January of 2015.
“We are pleased to provide this technology to patients who can
benefit from the Alteon Tapered Wedge Stem,” said Exactech CEO
David Petty. “This design philosophy represents about 40 percent of
the market for cementless stems in the U.S. This new products gives
us an opportunity to reach many more patients needing total hip
replacement.”
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Exactech, Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.comorExactech,
Inc.Media contactPriscilla Bennett, 352-377-1140Director Marketing
Communication & Public Relations
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024